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Abstract 
In this paper, I discuss how three funding agencies have presented or discussed the 
concept of cognitive innovation in formulating their research programs, calls or fund-
ing opportunities on their website. Gummerum and Denham recognize the associa-
tion between the innovator, innovation and the contextual challenge of the concept 
of cognitive innovation and its impact on society (Gummerum & Denham, 2014). Re-
search funders make decisions to allocate resources to certain research questions 
and not others. Researchers attempt to understand how these decisions are made 
and consider them in applying for funding to them. One of the information sources 
that researchers can use to inform what areas of research they can get funding for or 
how to formulate their research grants is the public information on the website of 
the funding agencies. In this paper, I only focus on the information presented on their 
website and not their internal processes or policies. The approach of funding agen-
cies to present what is categorized as innovation or creativity has the potential to 
influence how researchers focus or frame their research. 
Keywords: innovation; research funder; research grant; research system. 
 
Three funding agencies have been included in this paper: NIHR (National Institute 
for Health Research, UK), ZonMW (The Netherlands Organization for Health Re-
search and Development, the Netherlands) and PCORI (Patient-Centered Outcomes 
Research Institute, USA). These agencies were identified as champions in dealing 
with issues of reducing research waste and adding value to research in a previous 
study (Nasser et al., 2017). This article shows that there is a lack of clarity on their 
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website in defining and outlining the concept of innovative or creative in formulating 
calls for research projects or programs and their underpinning evidence of what 
leads to innovation. Based on the information available on their website, it seems 
that some agencies assume that the background and achievements of individual re-
searchers are the main catalysts, others consider collaboration with the industry as 
a key catalyst, and finally one organization considers developing new methods a key 
step that can lead to innovation. It was not clear how the organization evaluated and 
measured whether the strategies worked and were successful. 
Gummerum and Denham recognize the association between the innovator, innovation 
and the contextual challenge of the concept cognitive innovation and its impact on so-
ciety (Gummerum & Denham, 2014). Despite the wide use of the term “innovation” to 
describe certain research projects, only a tiny fraction of research projects are truly 
disruptively innovative and it has been suggested that the drive for innovation can in-
appropriately reduce the conduct of replication studies (Ioannidis, 2016; Ioannidis, 
Bo⁠yack, Small, Sorensen, & Klavans, 2014). Studies tend to deliberately be different in 
one or other minor aspect to justify getting resources or support to conduct the study.  
Research funders make decisions on how to allocate resources to certain research 
questions and not others. Researchers attempt to understand how these decisions 
are made and consider them in applying for funding to the funding agencies. One of 
the information sources that researchers use to inform these decisions is the public 
information on the website of the research funding agencies. In this paper, I discuss 
how three funding agencies have presented or discussed the concept of cognitive in-
novation in formulating their research programs, calls or funding opportunities on 
their websites. This does not reflect the internal policies of the funding agencies, as I 
did not conduct in-depth interviews or ethnographies studies for each funding 
agency. The public information of the funding agency demonstrates the public image 
of the funding agency and how it might be perceived by researchers.  
In a previous project, we conducted an evaluation of the websites of 12 research fun-
ders on how they address issues on reducing research waste; three research funders 
demonstrated the best strategies to manage the issue of reducing research waste and 
adding value to research: NIHR (UK), ZonMW (the Netherlands), and PCORI (USA), 
(Nasser et al., 2017). This reflects their commitments to add value to research, en-
sure that standards of research integrity are met and more evidence based. There-
fore, I focused on these three organizations.  
 
The National Institute for Health Research (NIHR) 
NIHR is the key applied health research funder in UK. They expect that researchers 
work with patients and members of the public in designing and implementing the 
research projects, and that they demonstrate that the findings can potentially have 
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an effect on patient health in a reasonable timeframe. NIHR has a range of programs 
focusing on different research topics, including health services and delivery research, 
invention for innovation, health technology assessment (HTA) and public health re-
search. There are two relevant programs on the NIHR website to this evaluation. One 
is active (invention for innovation; NIHR, 2017a), and one is currently on hold: Re-
search for Innovation Speculation and Creativity (RISC; NIHR, 2017c).  
The invention for innovation program is described as translational funding scheme 
focusing on advances in health care technologies, devices and interventions to in-
crease patient benefit. It focuses on the innovation itself, the context and certain as-
pects of societal domain (but not the innovators themselves). It describes an 
invention as something that can increase patient benefit but also be adopted and 
commercialized. They are further described as two streams—the product develop-
ment awards and challenge awards—both focusing on technology. Terms like “dis-
ruptive” are used to describe them without providing further clarification. The 
innovator is not discussed in detail beyond the organizations that they are affiliated 
with. The project requires collaboration between two or more of these organizations 
(higher education institutes, institutes associated with national health services 
(NHS), private industry). In the description of the guideline for applicants, they out-
line six criteria to inform prioritizing allocating resources to a project; one of them is 
level of innovation. The concept of innovation was described as “how the proposed 
device, technology or intervention presents a significant level of innovation, provid-
ing an advance over currently commercially available products. The application must 
contain an explanation of how adoption of the technology would change clinical prac-
tice and how the project will generate data to drive adoption” (NIHR, 2017b, p. 8). It 
doesn’t describe in this section what they mean by “change clinical practice.” They 
do describe in other sections the issue “increase patient benefit” (which is what they 
might be referring to).  
 
The Netherlands Organization for Health Research and Development (ZonMW) 
ZonMW’s main commissioners are the ministry of health, welfare and sport and the 
Netherlands Organizations for Scientific Research, so its focus is on projects related 
to improving health and health care in the Netherlands. The organization not only 
focuses on conduct of health research but also on implementing research findings. 
ZonMW has a funding program called Innovative Research Incentives Scheme 
(Veni; ZonMW, 2016); they say that its focus is “the Veni target group consists of 
excellent researchers with a striking and original talent as well a considerable fas-
cination for doing challenging and pioneering research. The focus in this respect is 
on innovative and curiosity-driven research.” However, they do not describe the 
definition of “innovative.” 
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There are not many details on how they adapted the processes to ensure that cre-
a⁠tive and innovative projects get prioritized. The calls were open and responsive, not 
commissioned and pre-defined. Studies intending to identify effective approaches to 
peer review research grants raised concerns that commissioning research (instead 
of having open calls) can hinder the creativity and innovation in research base 
(Staley & Hanley, 2008). That can explain the choice of this type of research grant 
call. This research program focuses on the innovator, innovation (although not de-
scribed in detail how this is defined) and its societal impact.  
 
The Patient-Centered Outcome Research Institute (PCORI) 
PCORI has a legislative mandate “to assist patients, clinicians, purchasers and policy 
makers in making informed health decision by advancing the quality and relevance of 
evidence concerning the manner in which diseases, disorders, and other health con-
ditions can effectively and appropriately be prevented, diagnosed, treated, monitored, 
and managed through research and evidence synthesis that considers variations in 
patient subpopulations, and the dissemination of research findings with respect to the 
relative health outcomes, clinical effectiveness, and appropriateness of the medical 
treatments, services, and [other] items” (PCORI, 2013b, p. 2). They have identified 
ad⁠vancement in methodology as key step to be innovative in research. They acknow-
ledge that our current research methods to evaluate health care intervention for pa-
tients and community are not optimal and we need innovative and new methods in 
health services research. They are looking for a new model of research and innovation 
that introduces a better balance between evidence generation using sound methods 
and the acceptance and utilization of them. The two key areas that they identified in-
clude: (a) developing consensus standards for research, (b) identifying gaps in pa-
tient’s needs. As part of this concept, they introduced and awarded the PCORI 
challenge initiative 2013 called the PCORI matchmaking pap challenge. The winner 
proposed a platform that let users propose, endorse and pledge funds for research 
question and topics and researchers to apply for funding to conduct studies on the 
topics that have met their fundraising goals (PCORI, 2013a). These programs primar-
ily focus on the innovation and its context and societal impact.  
 
Conclusions 
This is an overview on examples how these three national research funders com-
municated the concept of innovation and creativity in their research programs on 
their websites. The article demonstrates that there is a lack of clarity in defining the 
concept of innovation and creativity in shaping research grant programs and pro-
cess and their underlying evidence around it on the websites. There seem to be un-
derlying assumptions regarding what can lead to innovation, although the 
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underlying evidence is not always comprehensively reported—assumptions like 
supporting talented and high-achieving individuals (ZonMw), collaborating with in-
dustry (NIHR), or developing new methods can lead to innovation (PCORI). Moreo-
ver, it is unclear how the agencies evaluate whether their strategies were successful 
in achieving innovation or creativity.  
This is not a full reflection of how the funding agencies conceptualize innovation 
and creativity or how researchers perceive it. A lot of internal discussion and poli-
cies are not communicated on the website. Researchers engage with staff members 
of funding agencies and experts in grant applications in universities and research 
institutes to decide how to formulate research grant applications. An in-depth eval-
uation including interviews with individuals in the funding agencies and research-
ers applying to the grant programs along with ethnographic studies on the 
processes in the funding agencies is required.  
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